These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey. Cuspidi C; Ambrosioni E; Mancia G; Pessina AC; Trimarco B; Zanchetti A; J Hypertens; 2002 Jul; 20(7):1307-14. PubMed ID: 12131527 [TBL] [Abstract][Full Text] [Related]
31. Retinal arteriole-to-venule ratio changes and target organ disease evolution in newly diagnosed hypertensive patients at 1-year follow-up. Coll-de-Tuero G; González-Vázquez S; Rodríguez-Poncelas A; Barceló MA; Barrot-de-la Puente J; Penedo MG; Pose-Reino A; Pena-Seijo M; Saez M J Am Soc Hypertens; 2014 Feb; 8(2):83-93. PubMed ID: 24239162 [TBL] [Abstract][Full Text] [Related]
32. Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment. Dahlöf B; Stenkula S; Hansson L Blood Press; 1992 May; 1(1):35-44. PubMed ID: 1345141 [TBL] [Abstract][Full Text] [Related]
34. The frequency of combined target organ damage and the beneficial effect of ambulatory blood pressure monitoring in never treated mild-to-moderate hypertensive patients. Torun D; Sezer S; Arat Z; Pelit A; Yigit F; Ozdemir FN Int Heart J; 2005 Nov; 46(6):1073-82. PubMed ID: 16394603 [TBL] [Abstract][Full Text] [Related]
35. Differential effect of obesity on prevalence of cardiac and carotid target organ damage in hypertension (the Campania Salute Network). Mancusi C; Gerdts E; Losi MA; D'Amato A; Manzi MV; Canciello G; Trimarco V; De Luca N; de Simone G; Izzo R Int J Cardiol; 2017 Oct; 244():260-264. PubMed ID: 28629621 [TBL] [Abstract][Full Text] [Related]
36. Optimizing global risk evaluation in primary hypertension: the role of microalbuminuria and cardiovascular ultrasonography. Viazzi F; Parodi D; Leoncini G; Vettoretti S; Ratto E; Vaccaro V; Ravera M; Tomolillo C; Bezante GP; Del Sette M; Deferrari G; Pontremoli R J Hypertens; 2004 May; 22(5):907-13. PubMed ID: 15097229 [TBL] [Abstract][Full Text] [Related]
37. Ambulatory blood pressure, target organ damage and left atrial size in never-treated essential hypertensive individuals. Cuspidi C; Meani S; Valerio C; Fusi V; Catini E; Sala C; Zanchetti A J Hypertens; 2005 Aug; 23(8):1589-95. PubMed ID: 16003187 [TBL] [Abstract][Full Text] [Related]
38. Retinal changes and cardiac remodelling in systemic hypertension. Cuspidi C; Negri F; Giudici V; Sala C Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):205-14. PubMed ID: 19451180 [TBL] [Abstract][Full Text] [Related]
39. Mild renal dysfunction and cardiovascular risk in hypertensive patients. Leoncini G; Viazzi F; Parodi D; Ratto E; Vettoretti S; Vaccaro V; Ravera M; Deferrari G; Pontremoli R J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S88-90. PubMed ID: 14684681 [TBL] [Abstract][Full Text] [Related]
40. Target organ damage in hypertensive patients: correlation between retinal arteriovenular ratio and left ventricular geometric patterns. Meazza R; Scardino C; Grosso Di Palma L; Perrucci GL; Gallazzi E; Cattaneo M; Villarini A; Magrini F J Hum Hypertens; 2014 Apr; 28(4):274-8. PubMed ID: 23903196 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]